166 related articles for article (PubMed ID: 29550394)
1. Construction of diagnosis system and gene regulatory networks based on microarray analysis.
Hong CF; Chen YC; Chen WC; Tu KC; Tsai MH; Chan YK; Yu SS
J Biomed Inform; 2018 May; 81():61-73. PubMed ID: 29550394
[TBL] [Abstract][Full Text] [Related]
2. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
3. Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression.
Du F; Li Y; Zhang W; Kale SP; McFerrin H; Davenport I; Wang G; Skripnikova E; Li XL; Bowen NJ; McDaniels LB; Meng YX; Polk P; Liu YY; Zhang QJ
Tumour Biol; 2016 Aug; 37(8):11147-11162. PubMed ID: 26935058
[TBL] [Abstract][Full Text] [Related]
4. Knowledge-guided multi-scale independent component analysis for biomarker identification.
Chen L; Xuan J; Wang C; Shih IeM; Wang Y; Zhang Z; Hoffman E; Clarke R
BMC Bioinformatics; 2008 Oct; 9():416. PubMed ID: 18837990
[TBL] [Abstract][Full Text] [Related]
5. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency.
Yeh HY; Cheng SW; Lin YC; Yeh CY; Lin SF; Soo VW
BMC Med Genomics; 2009 Dec; 2():70. PubMed ID: 20025723
[TBL] [Abstract][Full Text] [Related]
6. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.
Zou J; Yin F; Wang Q; Zhang W; Li L
Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572
[TBL] [Abstract][Full Text] [Related]
7. A prognostic 11 genes expression model for ovarian cancer.
Men CD; Liu QN; Ren Q
J Cell Biochem; 2018 Feb; 119(2):1971-1978. PubMed ID: 28817186
[TBL] [Abstract][Full Text] [Related]
8. Feature selection and nearest centroid classification for protein mass spectrometry.
Levner I
BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
[TBL] [Abstract][Full Text] [Related]
9. A Decision Tree Based Classifier to Analyze Human Ovarian Cancer cDNA Microarray Datasets.
Tsai MH; Wang HC; Lee GW; Lin YC; Chiu SH
J Med Syst; 2016 Jan; 40(1):21. PubMed ID: 26531754
[TBL] [Abstract][Full Text] [Related]
10. Development of two-stage SVM-RFE gene selection strategy for microarray expression data analysis.
Tang Y; Zhang YQ; Huang Z
IEEE/ACM Trans Comput Biol Bioinform; 2007; 4(3):365-81. PubMed ID: 17666757
[TBL] [Abstract][Full Text] [Related]
11. An integrated algorithm for gene selection and classification applied to microarray data of ovarian cancer.
Lee ZJ
Artif Intell Med; 2008 Jan; 42(1):81-93. PubMed ID: 18006289
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome.
Cai SY; Yang T; Chen Y; Wang JW; Li L; Xu MJ
J Ovarian Res; 2015 Jul; 8():50. PubMed ID: 26228058
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data.
Abdallah R; Chon HS; Bou Zgheib N; Marchion DC; Wenham RM; Lancaster JM; Gonzalez-Bosquet J
Int J Gynecol Cancer; 2015 Jul; 25(6):1000-9. PubMed ID: 26098088
[TBL] [Abstract][Full Text] [Related]
14. Data Mining for Identification of Molecular Targets in Ovarian Cancer.
Villegas-Ruiz V; Juarez-Mendez S
Asian Pac J Cancer Prev; 2016; 17(4):1691-9. PubMed ID: 27221839
[TBL] [Abstract][Full Text] [Related]
15. An Integrated Feature Selection Algorithm for Cancer Classification using Gene Expression Data.
Ahmed S; Kabir M; Ali Z; Arif M; Ali F; Yu DJ
Comb Chem High Throughput Screen; 2018; 21(9):631-645. PubMed ID: 30569852
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
Morais-Rodrigues F; Silv Erio-Machado R; Kato RB; Rodrigues DLN; Valdez-Baez J; Fonseca V; San EJ; Gomes LGR; Dos Santos RG; Vinicius Canário Viana M; da Cruz Ferraz Dutra J; Teixeira Dornelles Parise M; Parise D; Campos FF; de Souza SJ; Ortega JM; Barh D; Ghosh P; Azevedo VAC; Dos Santos MA
Gene; 2020 Feb; 726():144168. PubMed ID: 31759986
[TBL] [Abstract][Full Text] [Related]
17. Profiling studies in ovarian cancer: a review.
Fehrmann RS; Li XY; van der Zee AG; de Jong S; Te Meerman GJ; de Vries EG; Crijns AP
Oncologist; 2007 Aug; 12(8):960-6. PubMed ID: 17766655
[TBL] [Abstract][Full Text] [Related]
18. Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
Xu W; Rao Q; An Y; Li M; Zhang Z
PLoS One; 2018; 13(8):e0202763. PubMed ID: 30138346
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.
Matondo A; Jo YH; Shahid M; Choi TG; Nguyen MN; Nguyen NNY; Akter S; Kang I; Ha J; Maeng CH; Kim SY; Lee JS; Kim J; Kim SS
Sci Rep; 2017 Aug; 7(1):9689. PubMed ID: 28851888
[TBL] [Abstract][Full Text] [Related]
20. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
